Responses were rapid and durable, and tumour shrinkage was observed in 82 percent of patients[i] New findings from this investigational study build on the strength of the data for amivantamab in ...
The model showed strong discriminatory performance, with a time-dependent AUC of 0.69 for the prophylaxis strategy and 0.85 ...
Ways parents can turn study abroad into a career-launching opportunity: Indian students are strategically planning overseas ...
A new study published in the journal of Pediatric Nephrology revealed an U-shaped relationship between serum uric acid levels and cardiovascular risk in children with chronic kidney disease ...
Responses were rapid and durable, and tumor shrinkage was observed in 82 percent of patients New findings from this investigational study build on the strength ...
Johnson & Johnson (NYSE:JNJ) today announced promising new results from the Phase 1b/2 OrigAMI-4 study evaluating the efficacy and safety of subcutaneous (SC) amivantamab monotherapy in patients with ...
We may earn a commission from links on this page. Did you know you can customize Google to filter out garbage? Take these steps for better search results, including adding Lifehacker as a preferred ...
My journey, right from deciding on Germany to finally setting foot here, was nothing short of a rollercoaster. Choosing ...
Bellmunt J, Hussain M, Gschwend JE, et al. Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback